What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
Authors:
- 15 February 2005
- journal article
- review article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 8 (2) , 167-173
Abstract
The purpose of this paper to identify the optimal therapy after radical prostatectomy (RP) for patients with adenocarcinoma of the prostate invading the seminal vesicles (pT3bN0M0 or SVI). A PubMed search using the keywords ‘prostate’, ‘seminal vesicle’, ‘prostatectomy’, ‘radiotherapy’, ‘androgen blockade’ was performed to identify literature regarding rates of disease failure in patients with SVI who are observed or treated with androgen blockade (AB), radiotherapy (RT) or RT+AB after RP. The outcome of 68 patients treated at Duke University with post-operative AB, RT or RT+AB for pT3bN0M0 is also presented. More than 70% of patients with SVI develop disease recurrence after surgery. For many, recurrence occurs within 2 y after RP. These patients have poor control rates with postoperative RT alone. While experience with AB and RT+AB is limited, control rates are generally superior to RT alone. At Duke University, after a median follow-up of nearly 4 y, patients treated with RT+AB or AB alone for pT3bN0M0 achieved better 5-y progression-free survival (PFS) compared with those who received RT alone (78 and 68 vs 30%, P=0.03 and 0.046, respectively). There was no PFS difference between those who received AB alone or RT+AB (68 vs 78%, P=0.5). Seminal vesicle invasion confers a poor prognosis after RP. SVI is a consistent predictor of poor outcome after RT. The limited data available examining AB and RT+AB in pT3bN0M0 disease, including data from Duke University, are encouraging. Nonetheless, postoperative AB, RT and RT+AB for pT3bN0M0 disease require prospective evaluation, as RP alone is rarely curative.Keywords
This publication has 33 references indexed in Scilit:
- Predictors of prostate‐specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomyCancer, 2004
- Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factorsUrology, 2004
- Biochemical And Pathological Predictors Of The Recurrence Of Prostatic Adenocarcinoma With Seminal Vesicle InvasionJournal of Urology, 2003
- Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostateRadiotherapy and Oncology, 2001
- PROGNOSTIC INDICATORS IN PATIENTS WITH SEMINAL VESICLE INVOLVEMENT FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinomaCancer, 1998
- The results of radical retropubic prostatectomy and adjuvant therapy for pathologic Stage C prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, 1995
- Multivariate analysis of factors predicting local relapse after radical prostatectomy—possible indications for postoperative radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991